Fidelity Investments’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
368,529
+362,528
| +6,041% | +$1.98M | ﹤0.01% | 2485 |
|
|
2025
Q1 | $37.7K | Buy |
6,001
+1,641
| +38% | +$10.3K | ﹤0.01% | 3978 |
|
|
2024
Q4 | $18K | Buy |
4,360
+665
| +18% | +$2.74K | ﹤0.01% | 4221 |
|
|
2024
Q3 | $12.3K | Buy |
3,695
+91
| +3% | +$304 | ﹤0.01% | 4355 |
|
|
2024
Q2 | $10.7K | Buy |
3,604
+69
| +2% | +$206 | ﹤0.01% | 4303 |
|
|
2024
Q1 | $12.2K | Buy |
3,535
+24
| +0.7% | +$83 | ﹤0.01% | 4193 |
|
|
2023
Q4 | $4.71K | Buy |
3,511
+1,931
| +122% | +$2.59K | ﹤0.01% | 4463 |
|
|
2023
Q3 | $3.44K | Buy |
1,580
+694
| +78% | +$1.51K | ﹤0.01% | 4414 |
|
|
2023
Q2 | $2.12K | Buy |
+886
| New | +$2.12K | ﹤0.01% | 4576 |
|
|
2022
Q4 | – | Sell |
-1,560,125
| Closed | -$2.4M | – | 5597 |
|
|
2022
Q3 | $2.4M | Buy |
1,560,125
+1,476,900
| +1,775% | +$2.27M | ﹤0.01% | 2385 |
|
|
2022
Q2 | $234K | Buy |
+83,225
| New | +$234K | ﹤0.01% | 3090 |
|
|
2021
Q2 | – | Sell |
-576,500
| Closed | -$1.57M | – | 4877 |
|
|
2021
Q1 | $1.57M | Hold |
576,500
| – | – | ﹤0.01% | 2508 |
|
|
2020
Q4 | $1.4M | Sell |
576,500
-216,200
| -27% | -$523K | ﹤0.01% | 2467 |
|
|
2020
Q3 | $3.2M | Hold |
792,700
| – | – | ﹤0.01% | 2190 |
|
|
2020
Q2 | $5.22M | Hold |
792,700
| – | – | ﹤0.01% | 2036 |
|
|
2020
Q1 | $2.61M | Hold |
792,700
| – | – | ﹤0.01% | 2124 |
|
|
2019
Q4 | $2.97M | Hold |
792,700
| – | – | ﹤0.01% | 2164 |
|
|
2019
Q3 | $3.57M | Hold |
792,700
| – | – | ﹤0.01% | 2135 |
|
|
2019
Q2 | $5.95M | Buy |
+792,700
| New | +$5.95M | ﹤0.01% | 2044 |
|